Watch Ticker

Adagene Inc. American Depositary Shares

Go to Adagene Inc. American Depositary Shares Website

$1.93

0.03 (1.62%)

Live

Previous Close

$1.8992

Day Range

$0 - $0

Previous Day Range

$1.86 - $1.9598

Market Cap

$90.2 million USD

Day Vol.

Previous Day Vol.

7435

Currency

USD

Primary Exchange

Nasdaq

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of mon...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Adagene Inc. - Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA

Adagene received FDA feedback on its clinical development plan for muzastotug (ADG126), an anti-CTLA-4 therapy for microsatellite stable colorectal cancer, with plans to begin Phase 2 patient enrollment in 2H 2025.

Related tickers: ADAG, MRK.

Read Full Article

Adagene Inc. - Adagene announces up to $25 million strategic investment from Sanofi

Sanofi will invest up to $25 million in Adagene, exercise an option on a third SAFEbody discovery program, and sponsor a combination clinical trial for muzastotug in advanced solid tumors. The investment is expected to extend Adagene's cash runway into 2027.

Related tickers: ADAG, SNY.

Read Full Article

Trending Tickers

Please sign in to view